{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Li S"],"funding":["Jiangsu Province Natural Science Foundation","Fundamental Research Funds for the Central Universities","Fujian Provincial Natural Science Foundation","Basic and Applied Basic Research Foundation of Guangdong Province","Guangzhou Municipal Science and Technology Project","National Natural Science Foundation of China"],"pagination":["252-273"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12754226"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["58"],"pubmed_abstract":["Infrapatellar fat pad mesenchymal stem cells (IPFP-MSCs) extracellular vesicles (EVs) are found to be capable of accelerating Osteoarthritis (OA) progression. However, which pathways and which pathogenic EVs subgroups are involved are not defined. In our study we found that there were a higher percentage of TOMM20<sup>+</sup> EV's within the total synovial fluid EV's from OA patients than from trauma patients as well as increased mtDNA content. This implicates the mitochondria derived EV sub-group - mitochondria derived vesicles (MDVs) as a potential driver in OA. We found with the single-cell data that MDVs may be secreted from IPFP-MSCs with VPS35. Furthermore, these cells were harvested from the body of the OA patient. IPFP-MSC derived MDVs can deliver exogenous mtDNA to chondrocytes by"],"journal":["Bioactive materials"],"pubmed_title":["Extracellular vesicles from IPFP-MSCs trigger osteoarthritis by transferring mtDNA."],"pmcid":["PMC12754226"],"funding_grant_id":["2025A1515012604","20241A011044","82300018","82172098","2024J01221","21624220","82202344","BK20241808"],"pubmed_authors":["Liu H","Feng Z","Sun B","Ma Y","Su J","Zheng W","Dai Z","Liu W","Cheng T","Yan Z","Li S","Zhang Z","Lu H","Zhi X","Chen W","Zhang B","Zhao J"],"additional_accession":[]},"is_claimable":false,"name":"Extracellular vesicles from IPFP-MSCs trigger osteoarthritis by transferring mtDNA.","description":"Infrapatellar fat pad mesenchymal stem cells (IPFP-MSCs) extracellular vesicles (EVs) are found to be capable of accelerating Osteoarthritis (OA) progression. However, which pathways and which pathogenic EVs subgroups are involved are not defined. In our study we found that there were a higher percentage of TOMM20<sup>+</sup> EV's within the total synovial fluid EV's from OA patients than from trauma patients as well as increased mtDNA content. This implicates the mitochondria derived EV sub-group - mitochondria derived vesicles (MDVs) as a potential driver in OA. We found with the single-cell data that MDVs may be secreted from IPFP-MSCs with VPS35. Furthermore, these cells were harvested from the body of the OA patient. IPFP-MSC derived MDVs can deliver exogenous mtDNA to chondrocytes by","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Apr","modification":"2026-07-15T13:25:06.872Z","creation":"2026-07-05T03:08:29.085Z"},"accession":"S-EPMC12754226","cross_references":{"pubmed":["41480405"],"doi":["10.1016/j.bioactmat.2025.11.046"]}}